However, newer evidence suggests that pharmacologic therapy can reduce fat mass while preserving or enhancing muscle performance
Jebb emphasized that GLP-1 drugs "are a really valuable tool in obesity treatment but obesity is a chronic relapsing condition." "One would expect that these treatments need to be continued for life, just in the same way as blood pressure medication," Jebb said
In a randomized, double-blind, placebo-controlled clinical proof of concept study with chronic HBV patients, EDP-514 was safe and well-tolerated
In vitro , Ma and colleagues [90] also showed liraglutide to reduce H 2 O 2 -related damage in RGCs through inhibition of mitophagy induction, primarily by reducing ROS and maintaining mitochondrial membrane potential
Por lo tanto, los pacientes deben permanecer en estrecha comunicacin con sus proveedores con respecto a la continuidad del tratamiento